Podcast
Questions and Answers
Describe how the amplification of an initial signal occurs in signaling pathways, providing at least two distinct mechanisms with specific examples from the text.
Describe how the amplification of an initial signal occurs in signaling pathways, providing at least two distinct mechanisms with specific examples from the text.
Amplification occurs through: 1. Activation of multiple downstream kinases by a single activated kinase (e.g., Raf activating many kinases). 2. Production of numerous second messenger molecules by activated enzymes (e.g., PLC-γ generating DAG and IP3). Also, the release of preformed second messenger $Ca^{2+}$ can activate many further molecules (e.g.calmodulin)
Explain the structural composition of the T cell receptor (TCR) complex and delineate the roles of its variable and invariant components in antigen recognition and signal transduction.
Explain the structural composition of the T cell receptor (TCR) complex and delineate the roles of its variable and invariant components in antigen recognition and signal transduction.
The TCR complex consists of variable antigen-recognition proteins (TCR) and invariant signaling proteins (CD3 ε, δ, γ, ε chains and the 2 ζ chains). The TCR binds to the antigen, while the CD3 and ζ chains contain ITAMs that initiate signaling upon antigen binding.
Define ITAMs and outline their function in the context of antigen receptor signaling, specifically detailing the molecular events that occur following the binding of a cognate peptide/MHC to the TCR.
Define ITAMs and outline their function in the context of antigen receptor signaling, specifically detailing the molecular events that occur following the binding of a cognate peptide/MHC to the TCR.
ITAMs (Immunoreceptor Tyrosine-based Activation Motifs) are cytoplasmic recognition motifs containing two tyrosine residues. Upon cognate peptide/MHC binding to the TCR. ITAMs get phosphorylated, which then recruit signaling proteins with tandem SH2 domains.
Contrast the roles of ZAP-70 and Syk kinases in antigen receptor signaling, specifying which receptor complex each is associated with and how they contribute to downstream signaling events.
Contrast the roles of ZAP-70 and Syk kinases in antigen receptor signaling, specifying which receptor complex each is associated with and how they contribute to downstream signaling events.
Describe the dual role of the co-receptors CD4 and CD8 in enhancing T cell receptor signaling, detailing how they contribute to both the stabilization of the TCR-MHC complex and the phosphorylation of ITAMs.
Describe the dual role of the co-receptors CD4 and CD8 in enhancing T cell receptor signaling, detailing how they contribute to both the stabilization of the TCR-MHC complex and the phosphorylation of ITAMs.
How does ZAP-70's phosphorylation of LAT and SLP/76 result in enhanced integrin activation and adhesiveness?
How does ZAP-70's phosphorylation of LAT and SLP/76 result in enhanced integrin activation and adhesiveness?
Explain the role of Akt in promoting cell survival and how it connects to metabolic activity within T cells after TCR signaling.
Explain the role of Akt in promoting cell survival and how it connects to metabolic activity within T cells after TCR signaling.
Describe the mechanism by which the rapamycin-FKBP complex inhibits cell growth and proliferation. Why is this useful in the context of transplant rejection?
Describe the mechanism by which the rapamycin-FKBP complex inhibits cell growth and proliferation. Why is this useful in the context of transplant rejection?
How do transcription factors activated by ZAP-70 contribute to the adaptive immune response?
How do transcription factors activated by ZAP-70 contribute to the adaptive immune response?
Explain how the drug Rapamycin (sirolimus) works on a molecular level.
Explain how the drug Rapamycin (sirolimus) works on a molecular level.
How does TCR signaling activation of Akt relate to increased metabolic activity?
How does TCR signaling activation of Akt relate to increased metabolic activity?
Describe how cytoskeletal rearrangement, initiated by ZAP-70, helps T cells perform their immune functions.
Describe how cytoskeletal rearrangement, initiated by ZAP-70, helps T cells perform their immune functions.
How does FcgRIII on NK cells mediate antibody-dependent cell cytotoxicity (ADCC), and what role do ITAM-containing chains play in this process?
How does FcgRIII on NK cells mediate antibody-dependent cell cytotoxicity (ADCC), and what role do ITAM-containing chains play in this process?
Describe the specific roles of LAT and SLP-76 as scaffold proteins in T cell signaling, and explain how their phosphorylation by ZAP-70 contributes to the activation of downstream signaling modules.
Describe the specific roles of LAT and SLP-76 as scaffold proteins in T cell signaling, and explain how their phosphorylation by ZAP-70 contributes to the activation of downstream signaling modules.
Explain how the activation of transcription factors, increased metabolic activity, cytoskeletal rearrangement, and enhanced integrin activation collectively contribute to T cell activation, proliferation, and differentiation following ZAP-70 phosphorylation of LAT and SLP-76.
Explain how the activation of transcription factors, increased metabolic activity, cytoskeletal rearrangement, and enhanced integrin activation collectively contribute to T cell activation, proliferation, and differentiation following ZAP-70 phosphorylation of LAT and SLP-76.
What are the implications of cytoskeletal rearrangement in the context of T cell activation, and how does this process facilitate the formation of the immunological synapse?
What are the implications of cytoskeletal rearrangement in the context of T cell activation, and how does this process facilitate the formation of the immunological synapse?
Rituximab is an anti-CD20 antibody that mediates its anti-cancer effects through ADCC. Outline the molecular events, initiated by Rituximab binding to CD20, that lead to the killing of cancer cells by NK cells.
Rituximab is an anti-CD20 antibody that mediates its anti-cancer effects through ADCC. Outline the molecular events, initiated by Rituximab binding to CD20, that lead to the killing of cancer cells by NK cells.
Explain why the phosphorylation of LAT and SLP-76 is crucial for the downstream activation of PLC-γ in antigen receptor signaling.
Explain why the phosphorylation of LAT and SLP-76 is crucial for the downstream activation of PLC-γ in antigen receptor signaling.
Describe the distinct roles of diacylglycerol (DAG) and inositol-triphosphate (IP3) in signal transduction following PLC-γ activation, and how each contributes to the activation of specific transcription factors.
Describe the distinct roles of diacylglycerol (DAG) and inositol-triphosphate (IP3) in signal transduction following PLC-γ activation, and how each contributes to the activation of specific transcription factors.
Explain the mechanism by which calcineurin activation leads to NFAT translocation into the nucleus, and why this step is essential for T cell activation.
Explain the mechanism by which calcineurin activation leads to NFAT translocation into the nucleus, and why this step is essential for T cell activation.
How does IL-2 signaling contribute to T cell activation, and why is blocking this signaling pathway a viable target for immunosuppression?
How does IL-2 signaling contribute to T cell activation, and why is blocking this signaling pathway a viable target for immunosuppression?
Describe the mechanism by which Cyclosporin A inhibits T cell activation at the molecular level, including the specific molecules involved and the ultimate effect on gene expression.
Describe the mechanism by which Cyclosporin A inhibits T cell activation at the molecular level, including the specific molecules involved and the ultimate effect on gene expression.
If a patient is prescribed Basiliximab post-transplant, how does this antibody's mechanism of action differ from that of Cyclosporin A in preventing T-cell activation and subsequent organ rejection?
If a patient is prescribed Basiliximab post-transplant, how does this antibody's mechanism of action differ from that of Cyclosporin A in preventing T-cell activation and subsequent organ rejection?
Explain how the combined action of NFAT, AP-1, and NF-kB transcription factors results in the expression of interleukin-2 (IL-2).
Explain how the combined action of NFAT, AP-1, and NF-kB transcription factors results in the expression of interleukin-2 (IL-2).
A researcher introduces a non-hydrolyzable analog of IP3 into T cells. What immediate effect would you expect to observe regarding intracellular calcium levels and subsequent NFAT activation? Explain your reasoning.
A researcher introduces a non-hydrolyzable analog of IP3 into T cells. What immediate effect would you expect to observe regarding intracellular calcium levels and subsequent NFAT activation? Explain your reasoning.
The recruitment and activation of PLC-g results in the generation of IP4 and DAG, which are crucial second messengers, initiating the activation of transcription factors.
The recruitment and activation of PLC-g results in the generation of IP4 and DAG, which are crucial second messengers, initiating the activation of transcription factors.
In T cells, the phosphorylation of CD27 enhances signaling, leading to the activation of PI3K and PLCg, subsequently activating the transcription factors NFAT, NFkB, and AP1.
In T cells, the phosphorylation of CD27 enhances signaling, leading to the activation of PI3K and PLCg, subsequently activating the transcription factors NFAT, NFkB, and AP1.
The ultimate outcome of T cell activation includes altered metabolic activity and survival, decreased adhesiveness, and inhibition of cytoskeletal rearrangements.
The ultimate outcome of T cell activation includes altered metabolic activity and survival, decreased adhesiveness, and inhibition of cytoskeletal rearrangements.
IL-2 functions as an autocrine T cell survival factor, and its signaling is therapeutically targeted by Cyclosporin A and Basiliximab, which are used in the treatment of bacterial infections.
IL-2 functions as an autocrine T cell survival factor, and its signaling is therapeutically targeted by Cyclosporin A and Basiliximab, which are used in the treatment of bacterial infections.
CTLA-4, primarily expressed on antigen-presenting cells, enhances T cell activation by binding to B7 molecules with lower affinity than CD28.
CTLA-4, primarily expressed on antigen-presenting cells, enhances T cell activation by binding to B7 molecules with lower affinity than CD28.
CTLA-4 genetic mutations leading to loss of function are typically associated with immunosuppression due to its inhibitory role in T cell activation.
CTLA-4 genetic mutations leading to loss of function are typically associated with immunosuppression due to its inhibitory role in T cell activation.
Checkpoint inhibitors, such as Ipilimumab, function by downregulating anti-tumor T cell responses, making them effective in treating autoimmune diseases but contraindicated in cancer therapy.
Checkpoint inhibitors, such as Ipilimumab, function by downregulating anti-tumor T cell responses, making them effective in treating autoimmune diseases but contraindicated in cancer therapy.
PD-L2, and not PD-1, is another co-inhibitory receptor on T cells targeted by antibodies in cancer therapy.
PD-L2, and not PD-1, is another co-inhibitory receptor on T cells targeted by antibodies in cancer therapy.
Inhibitory receptors enhance the immune response by recruiting protein or lipid phosphatases, which dephosphorylate key signaling molecules.
Inhibitory receptors enhance the immune response by recruiting protein or lipid phosphatases, which dephosphorylate key signaling molecules.
ITAMs (immunoreceptor tyrosine-based activation motifs) recruit activating phosphatases, which initiate downstream signaling cascades.
ITAMs (immunoreceptor tyrosine-based activation motifs) recruit activating phosphatases, which initiate downstream signaling cascades.
ITIMs (immunoreceptor tyrosine-based inhibition motifs) recruit inhibitory kinases such as SHP and SHIP to dampen immune cell activation.
ITIMs (immunoreceptor tyrosine-based inhibition motifs) recruit inhibitory kinases such as SHP and SHIP to dampen immune cell activation.
NK cells exclusively express activating receptors to identify and kill infected or damaged cells.
NK cells exclusively express activating receptors to identify and kill infected or damaged cells.
Activating receptors on NK cells recognize cell-surface proteins suppressed in target cells by stress or damage, leading to inhibition of cell killing.
Activating receptors on NK cells recognize cell-surface proteins suppressed in target cells by stress or damage, leading to inhibition of cell killing.
Inhibitory receptors on NK cells recognize surface molecules absent at high levels, such as MHC class III molecules, thereby preventing unwarranted cell death.
Inhibitory receptors on NK cells recognize surface molecules absent at high levels, such as MHC class III molecules, thereby preventing unwarranted cell death.
Signaling pathways commonly involve the inactivation of Ser/Thr kinases and tyrosine kinases.
Signaling pathways commonly involve the inactivation of Ser/Thr kinases and tyrosine kinases.
Signaling in immune cells exclusively leads to proliferation and differentiation, but not changes in cell shape or migration.
Signaling in immune cells exclusively leads to proliferation and differentiation, but not changes in cell shape or migration.
Phosphorylation of LAT and SLP-76 initiates the recruitment and activation of phospholipase C-g (PLC-$\gamma$).
Phosphorylation of LAT and SLP-76 initiates the recruitment and activation of phospholipase C-g (PLC-$\gamma$).
PLC-$\gamma$ activation leads to the activation of transcription factors NFAT, NF$\kappa$B, and AP1, which are independently sufficient for interleukin-2 expression.
PLC-$\gamma$ activation leads to the activation of transcription factors NFAT, NF$\kappa$B, and AP1, which are independently sufficient for interleukin-2 expression.
Diacylglycerol (DAG) recruits PKC-$ heta$ and RAS-GRP, subsequently leading to the activation of AP-1 and NF$\kappa$B.
Diacylglycerol (DAG) recruits PKC-$ heta$ and RAS-GRP, subsequently leading to the activation of AP-1 and NF$\kappa$B.
Inositol-triphosphate (IP3) directly activates NFAT by binding to it and altering its conformation.
Inositol-triphosphate (IP3) directly activates NFAT by binding to it and altering its conformation.
Calmodulin inhibits calcineurin activity by preventing its interaction with NFAT.
Calmodulin inhibits calcineurin activity by preventing its interaction with NFAT.
NFAT translocation to the nucleus is inhibited by its phosphorylation status, which is reversed by the action of calcineurin.
NFAT translocation to the nucleus is inhibited by its phosphorylation status, which is reversed by the action of calcineurin.
Blocking IL-2 transcription or autocrine IL-2 signaling enhances T cell activation by preventing negative feedback loops.
Blocking IL-2 transcription or autocrine IL-2 signaling enhances T cell activation by preventing negative feedback loops.
Cyclosporin A directly binds to and inhibits the catalytic activity of calcineurin.
Cyclosporin A directly binds to and inhibits the catalytic activity of calcineurin.
Basiliximab induces immunosuppression by directly inhibiting the phosphatase activity of calcineurin.
Basiliximab induces immunosuppression by directly inhibiting the phosphatase activity of calcineurin.
Flashcards
ITAM-linked receptors
ITAM-linked receptors
Receptors that pair with ITAM-containing chains to deliver activating signals.
ADCC
ADCC
An antibody-dependent cellular cytotoxicity; when NK cells recognize antibodies bound to target cells, inducing cell death.
ZAP-70
ZAP-70
A protein tyrosine kinase that phosphorylates LAT and SLP-76, initiating downstream signaling modules in T cell activation.
LAT & SLP-76
LAT & SLP-76
Signup and view all the flashcards
Downstream signaling modules
Downstream signaling modules
Signup and view all the flashcards
Signal Amplification
Signal Amplification
Signup and view all the flashcards
TCR Complex
TCR Complex
Signup and view all the flashcards
ITAMs
ITAMs
Signup and view all the flashcards
ITAM-Recruited Kinases
ITAM-Recruited Kinases
Signup and view all the flashcards
CD4/CD8 Co-receptors Role
CD4/CD8 Co-receptors Role
Signup and view all the flashcards
What is ZAP-70?
What is ZAP-70?
Signup and view all the flashcards
What are LAT and SLP-76?
What are LAT and SLP-76?
Signup and view all the flashcards
What are the 4 downstream modules after LAT/SLP-76 phosphorylation?
What are the 4 downstream modules after LAT/SLP-76 phosphorylation?
Signup and view all the flashcards
What is Akt?
What is Akt?
Signup and view all the flashcards
What are the main functions of Akt?
What are the main functions of Akt?
Signup and view all the flashcards
What is mTOR?
What is mTOR?
Signup and view all the flashcards
How does rapamycin work?
How does rapamycin work?
Signup and view all the flashcards
NFAT, NFkB, AP1
NFAT, NFkB, AP1
Signup and view all the flashcards
Phospholipase C-g (PLC-g)
Phospholipase C-g (PLC-g)
Signup and view all the flashcards
Diacylglycerol (DAG)
Diacylglycerol (DAG)
Signup and view all the flashcards
Inositol-triphosphate (IP3)
Inositol-triphosphate (IP3)
Signup and view all the flashcards
NFAT
NFAT
Signup and view all the flashcards
Calmodulin
Calmodulin
Signup and view all the flashcards
Calcineurin
Calcineurin
Signup and view all the flashcards
Cyclosporin A
Cyclosporin A
Signup and view all the flashcards
IP3 and DAG
IP3 and DAG
Signup and view all the flashcards
Key Transcription Factors Activated in T cells
Key Transcription Factors Activated in T cells
Signup and view all the flashcards
Co-stimulatory/Co-inhibitory Receptors
Co-stimulatory/Co-inhibitory Receptors
Signup and view all the flashcards
CD28 Co-stimulation
CD28 Co-stimulation
Signup and view all the flashcards
IL-2
IL-2
Signup and view all the flashcards
CTLA-4
CTLA-4
Signup and view all the flashcards
Checkpoint Inhibitors
Checkpoint Inhibitors
Signup and view all the flashcards
PD-1
PD-1
Signup and view all the flashcards
Inhibitory Receptors
Inhibitory Receptors
Signup and view all the flashcards
Mechanism of Inhibitory Receptors
Mechanism of Inhibitory Receptors
Signup and view all the flashcards
NK Cell Receptors
NK Cell Receptors
Signup and view all the flashcards
NK Activating Receptors
NK Activating Receptors
Signup and view all the flashcards
NK Inhibitory Receptors
NK Inhibitory Receptors
Signup and view all the flashcards
Signaling Pathway Features
Signaling Pathway Features
Signup and view all the flashcards
LAT and SLP-76
LAT and SLP-76
Signup and view all the flashcards
PLC-g activation
PLC-g activation
Signup and view all the flashcards
Ca2+
Ca2+
Signup and view all the flashcards
NFAT activation
NFAT activation
Signup and view all the flashcards
Study Notes
Below are the updated study notes:
Lymphocyte Receptor Signaling
- Literature: Chapter 7, Janeway's Immunobiology
- Lecture on "Pharmaceutical Immunology I" 535-0830-00L HS 2024, ETH Zurich, Prof. Dr. Cornelia Halin Winter
Adaptive Immune Response
- Many steps in the induction of an adaptive immune response require cell-cell interactions and signaling
- For example, activation of T cells by antigen-presenting dendritic cells, and B cell activation by T helper cells
Content
- General Principles of signal transduction and propagation
- Antigen receptor signaling and lymphocyte activation
- Co-stimulatory and inhibitory receptors
Essentials of T cell activation include:
- Self-study on General principles of signal transduction and propagation (p. 5-12)
- Following lecture on Antigen receptor signaling and lymphocyte activation
General Principles
- Transmembrane receptors convert extracellular signals into intracellular events.
- Signaling via immune receptors typically involves kinases and phosphatase
- Kinases phosphorylate proteins, such as receptor tyrosine kinases or intracellular Ser/Thr kinases
- Phosphatase remove phosphate groups from Ser/Thr
Phosphorylation
- Can activate or inactivate several proteins like enzymes and transcription factors
- Generates sites on proteins to which other signaling proteins can bind
Dephosphorylation
- Either blocks or activates a protein
Enzyme-associated Receptors
- Enzyme-associated receptors of the immune system can use intrinsic or associated protein kinases
- Receptor tyrosine kinases involve a kinase domain in an intrinsic part of the receptor. Ligand binding dimerizes the receptor, activating the kinases and phosphorylating each other
- Activated kinases can then phosphorylate downstream substates
- Other receptors have associated kinases that are non-covalently associated, where ligand binding dimerizes the receptor, activating the associated kinases and phosphorylating each other
- T cell, B cell receptors, and costimulatory molecule receptors (CD28, CD40) all use non-covalently associated kinases
Signaling Proteins
- Signaling proteins interact with each other and with lipid signaling molecules via modular protein domains in adaptor proteins or signaling enzymes
- SH2 domain: Found in Lck, ZAP-70, Fyn, Src, Grb2, PLC-y, STAT, Cbl, Btk, Itk, SHIP, Vav, SAP, PI3K and binds to phosphotyrosine, PYXXZ
- SH3 domain: Found in Lck, Fyn, Src, Grb2, Btk, Itk, Tec, Fyb, Nck, Gads and binds to proline, PXXP
- PH domain: Found in Tec, PLC-y, Akt, Btk, Itk, Sos and binds to phosphoinositides, PIP3
- PX domain: Found in P40phox, P47phox, PLD and binds to phosphoinositides, PI(3)P
- PDZ domain:Found in CARMA1 and binds to C termini of proteins, IESDV, VETDV
- C1 domain:Found in RasGRP, PKC-0 and binds to membrane lipid, diacylglycerol (DAG) phorbol ester
- NZF domain: Found in TAB2 and binds to polyubiquitin (K63-linked), polyubiquitinated RIP, TRAF-6, or NEMO
Scaffold Proteins
- Assembly of signaling complexes is mediated by scaffold and adaptor proteins
- Large proteins with numerous phosphorylation sites
- Bring many different signaling proteins together and confer membrane localization
- Activation of a protein kinase results in phosphorylation of a scaffold, recruiting signaling proteins that bing to it
- Enzymes and substrates brought together promote conformational changes via phosphorylation dependent recruitment
Adaptor Proteins
- Bring two different proteins together
- Example: adaptor protein Grb2 containing SH2 and SH3 domains
- The adapter Grb2 binds to the signaling protein Sos via its SH3 domains. An activated erythropoietin (Epo) receptor becomes tyrosine phosphorylated
- Grb2 then binds to the phosphotyrosine via its SH2 domain, bringing Sos to the receptor
Small G Proteins
- Important signaling molecules downstream of tyrosine kinase-associated receptors
- Family comprises more than 100 proteins
- Switched from inactive to active states by GEFs and the binding of GTP
- Ras, important in lymphocyte signaling, is often mutated in cancers (oncogene)
- Other examples are Rac, Rho, and Cdc42, which is important for cell migration and control changes in actin cytoskeleton
GEF
- Guanine-nucleotide exchange factor
Cell Membrane Recruitment
- Signaling proteins can be recruited to the cell membrane in in 3 main ways
- Scaffolds and adaptor proteins bind to phosphorylated sites
- Small G proteins that have lipid modifications naturally localize to membrane
- Protein domains recognizing lipid motifs (e.g. PH recognizing PIP3 )
- Extracellular signals are sensed by receptors at the cell membrane, which is also where membrane-localisation of signal transducers occurs
Signal Termination
- Signaling must be turned off as well as turned on through dephosphorylation of phosphorylated substrates, Ubiquitin-mediated degradation by proteasome, or Ubiquitin-mediated degradation in the Lysosome
- Two important post-transcriptional control mechanisms are phosphorylation / dephosphorylation and ubiquitinylation to induce targeted degradation (proteasome or lysosome)
Signal Amplification
- Signaling pathways amplify the initial signal; one activated kinase (e.g. Raf) can activate many further kinases
- Enzymes activated by signaling generate many products (e.g PLC- γ => DAG and IP3 )
- Release of preformed second messenger Ca2+ can activate many further molecules (e.g. calmodulin)
Antigen Receptor
- Antigen receptor signaling and lymphocyte activation
T Cell Receptor
- T cell receptor (TCR) complex: The TCR complex is made up of the variable antigen-recognition proteins (TCR) and invariant signaling proteins (CD3 ε, δ, γ, ε chains and the 2 ζ chains)
ITAMs
- Immunoreceptor Tyrosine-based Activation Motif
- Cytoplasmic recognition motifs containing two tyrosine residues
- Binding of cognate peptide/MHC to the TCR induces phosphorylation of the ITAM motifs. The T cell receptor complex contains 10 ITAMS
B cell Receptor
- B-cell receptor (BCR) complex: The BCR complex is made up of a cell-surface immunoglobulin with one each of the invariant signaling proteins Igα and Igβ
- The immunoglobulin recognizes the antigen but cannot by itself generate the signal
- Signaling is started via the phosphorylation of the ITAM motifs of the accessory chains Igα and Igß
- Signaling via the B cell receptor complex is mainly important during B cell development
- Regular activation of B cells occurs by the help of T cells and requires CD40L/CD40 signaling and cytokine signaling
ITAM Recruitment
- ITAMs recruit signaling proteins that have tandem SH2 domains
- Kinases Recruited to Phosphorylated ITAMs are T-cell receptor ZAP-70 and B-cell receptor Syk
Co-Receptors
- Engagement of the co-receptor CD4 or CD8 with the T cell receptor enhances phosphorylation of ITAMs
- Kinase Lck is bound to cytosolic part of CD4
- Once CD4 associates with the TCR complex, Lck phosphorylates ITAMs.
- Role of CD4 and CD8 is to provide stabilization of TCR-MHC complex and phosphorylation of ITAMs
Other Receptors
- Some receptors pair with ITAM-containing chains and deliver activating signals
- Example: FcyRIII on NK cells are activated by NK cells recognizing antibodies bound to target cells (e.g. a virally infected cell or cancer cell)
- Antibody-Fc binding to FcyRIII induces antibody-dependent cell cytotoxicity (ADCC); one mechanism of action of several anti-cancer antibodies
- Example: Rituximab (anti-CD20)
Downstream Signaling
- ZAP-70 phosphorylates the scaffold proteins LAT and SLP-76, initiating four downstream signaling modules: Activation of transcription factors, Increased metabolic activity, Cytoskeletal rearrangement, and enhanced integrin activation and adhesiveness
Phospholipase C-y (PLC-γ)
- Is activated by phosphorylation
- Activation ultimately results in activation of transcription factors: NFAT, NFKB, AP1 jointly required for expression of interleukin-2
- Recruitment and activation of phospholipase C-y (PLC-γ) is initiated by phosphorylation of the scaffold proteins LAT and SLP-76
C-y (PLC-γ) products
- C-y (PLC-γ) cleaves inositol phospho-lipids to generate two important signaling molecules including:
- Diacylglicero, remains in the membrane and recruits PKC-0 and RAS-GRP leading to activation of AP-1 and NFKB
- Inositol-triphosphate, opens calcium channels to induce Ca2+-release from the endoplasmatic reticulum (ER) leading to activation of NFAT
Influx in T cells
Ca2+
- influx in activated T cells leads to activation of the transcription factor NFAT
- This occurs because Ca2+ binds to and activates calmodulin. Ca2+ -complexed calmodulin then binds and activates calcineurin (phosphatase) to calcineurin dephosporylates, which translocates NFAT to the nucleus
NFAT
- Nuclear factor of activated T cells, essential for IL-2 transcription in activated T cells
- Blocking IL-2 transcription or blocking autocrine IL-2 signaling inhibits T cell activation
Therapeutic Immunosuppression
- Cyclosporin and Basiliximab are used for therapeutic immunosuppression
Cyclosporin A
- Trade name: Sandimmun, Neoral are cyclic peptide of eleven amino acids
- Natural substance from fungus (discovered 1971 at Sandoz) that has a strong immunosuppressant used for treatment or prevention of transplant rejection
- Forms a complex with an immunophilin, that inhibits Ca2+
- induced activation of the phosphatase calcineurin As a consequence, NFAT is not activated and the autocrine production of interleukin-2 is reduced and T cell activation is thus suppressed
Akt
- TCR signaling activates the serine/threonine kinase Akt which promotes cell survival by inhibiting cell death, and promotes metabolic activity via mTOR (mammalian target of rapamycin)
mTOR Inhibitors
- Rapamycin (sirolimus) was first isolated in 1972 from bacteria (streptomyces hygroscopicus) from Easter Island (Rapa Nui)
- Acts as a mammalian targetof rapamycin (mTOR) inhibitor as rapamycin binds the FK-binding protein (FKBP), inhibiting cell growth and proliferation by selectively blocking activation of the kinase mTOR by Raptor
- Approved for treatment of transplant rejection and considered a Regulatory Associated Protein of mTOR
Interaction
- Interaction of T cells with antigen-presenting cells through antigen recognition and co-stimulation-induced signaling leads to the formation of an immune synapse
Immune Synapse
- Large zone of cell-cell contact stabilized by adhesion molecules with peptide-MHC/TCR complexes and co-stimulatory molecules drawn into the synapse for cell-cell interactions lasting > 60 min
- Outcome of long-lasting T cell-APC interactions is T cell proliferations and differentiation to an effector cell
- The Composition of the immune synapse involves T cell, TCR, LFA-1, ICAM-1 CD4 and MHC with a secretory domain
CSMAC
- Inner ring of the immune synapse
- Comprises peptide-MHC/TCR complexes and costimulatory molecules
PSMAC
- Outer ring of the immune synapse
- comprises Adhesion molecules for stabilization with integrin LFA-1 on T cells and ICAM-1 on DC
- Functions include enabling effective signaling, targeted release of cytokines, and is important for T cell differentiation
Summary
- Antigen receptors associate with chains carrying ITAM (immunoreceptor tyrosine-based activation motifs)
- Activation of antigen receptors results in ITAM phosphorylation which triggers recruitment of further kinases (Zap-70 and Syk), phosphorylation of scaffold proteins and activation of PI3
- kinase and of PLC- γ
PI3
- kinase activation results in the deposition of PIP3 in the cell membrane, to which the kinase Akt can dock. - Activation can then lead to the enhancement of survival and metabolic activity via mTOR
- Finally, recruitment and activation of PLC-γ results in generation of IP3 and DAG and activation of transcription factors
Outcome
- Activation of various transcription factors: NFAT, NFKB, AP-1
- Altered metabolic activity and survival
- Adhesiveness and cytoskeletal rearrangements (stabilization of the immune synapse)
Co-Stimulatory
- Co-stimulatory and co-inhibitory receptors modulate antigen receptor signaling in T and B lymphocytes.
T-Cell
- T-cell co-stimulatory protein CD28 transduces signals that enhance antigen receptor signaling pathways
B7.1 and B7.2 are CD28 ligands expressed on specialized APCs and induce CD28 phosphorylation, activating PI 3-kinase to produce PIP3
- In T cells, the phosphorylation of CD28 enhances signaling and activates PI3K, PLC (DAG, IP3 ) leading to the activation of NFΑΤ, NFKB, AP1
- The overall simplified scheme depicts convergence of multiple signaling pathways on the IL-2 promoter to create IL-2 which is an autocrine T cell survival factor!
Autocrine
- Autocrine IL-2 signaling is therapeutically targeted by Cyclosporin A and Basiliximab (antibody directed against IL-2Ra)
- Both products are approved for treatment of graft rejection
CTLA-4
- T cell-expressed inhibitory receptor for B7 molecules
- Induced on activated T cells, downregulating T cell activation and is competitively binds to CD28 for B7 molecules (expressed by antigen presenting cells (APCs)
- CTLA-4 has higher affinity and avidity for B7 than CD28 and consequently outcompetes CD28- B7 binding, thereby inhibiting costimulatory signaling via CD28
- Genetic knockout or mutations in CTLA-4 are associated with autoimmunity
- CTLA-4-blocking antibodies (e.g. Ipilimumab) have recently been approved for anti-melanoma cancer therapy, and support the induction of anti-tumor T cell responses, becoming known as "checkpoint inhibitors
PD-1
- Other co-inhibitory receptor on T cells is PD-1, which is targeted by antibody
Regulatory Receptors
- Inhibitory receptors downregulate the immune response by recruiting protein or lipid phosphatases
- ITAM is an immunoreceptor tyrosine-based activation motif and helps to recruit activating kinases
- ITIM is an immunoreceptor tyrosine-based inhibition motif and helps to recruit inhibitory phosphatases such as SHP (SH2-containing phosphatase) and SHIP (SH2-containing inositol phosphatase)
NK cells
- Express activating and inhibitory receptors to distinguish between healthy and infected cells
Activating receptors
- Recognize cell-surface proteins induced in target cells by stress or damage which activates downstream signaling
Inhibitory receptors
- Recognize surface molecules constitutively expressed such as MHC class I molecules and inhibits downstream singaling
Missing MHC Class I
- A missing or absent MHC class I cannot stimulate a negative signal
- Activating Receptor signals dominates
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This resource explores T cell receptor (TCR) signaling, covering signal amplification, receptor structure, ITAM function, and the roles of ZAP-70/Syk kinases. It also details the co-receptor functions of CD4 and CD8 in enhancing the TCR signaling cascade.